What is a well-known metaphor for paediatrics also applies to early stage commercial forecasting and strategy. The point of forecasting at an early stage is very different to say a forecast at Phase 3. Foremost, it is not just about Forecasting Accuracy at least not primarily; this is about understanding and unlocking Value and not meant to plan for manufacturing capacity, stock levels or sales and marketing incentives. Hence while in the infancy of a product budgets are typically tighter but possible product value propositions are more numerous the process has to be managed very differently.
Members Only - register here
https://us06web.zoom.us/meeting/register/tZUtcOuuqDMqE9FzwBMchDPKfbem1g_EsagI
Webinar objectives:
groupH has been focusing on early stage commercial strategy for over 15 years, completed over 300 assignments and continuously refined our approach. This 60 minute webinar will describe the underlying philosophy and the basic modules required to successfully complete an early stage commercial assessment
We will:
- take the participants through various archetypes of situations and describe the differences in approach
- discuss the pros and cons of various forecasting methodologies and frameworks in light of different opportunities
- help you to understand the differences of going through this process in a smaller biotech or in a larger pharma organisation.
There is no one-size-fits-all, every project is unique in its way and many of the tools we are using or developing are too. Optimise value creation for your organisation and adopt a value based approach.
Take-aways for participants:
- Participants will learn how to put the idea of value at the heart of product development
- Participants will learn how to structure early stage commercial forecasting in different situations
- Participants will learn about the most common pitfalls and how to avoid them
- Participants will learn about the importance of payer value evidence
- Participants will learn how to ask the right questions and drive cross-functional alignment and organisational change [if necessary] that will optimise value creation.